ARTICLE | Clinical News
Genaera gets SPA for Evizon Phase IIIs
June 28, 2005 1:04 AM UTC
GENR received an SPA from FDA for two identical international Phase III trials of Evizon squalamine lactate to treat choroidal neovascularization (CNV) due to age-related macular degeneration (AMD). G...